$185 Million is the total value of Eversept Partners, LP's 54 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTL | Exit | VITAL THERAPIES INCput | $0 | – | -38,300 | -100.0% | -0.01% | – |
| AGTC | Exit | APPLIED GENETIC TECHNOL CORP | $0 | – | -14,500 | -100.0% | -0.05% | – |
| MLNT | Exit | MELINTA THERAPEUTICS INC | $0 | – | -26,479 | -100.0% | -0.05% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTDput | $0 | – | -25,000 | -100.0% | -0.06% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -27,000 | -100.0% | -0.15% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -149,100 | -100.0% | -0.15% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -0.19% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -40,018 | -100.0% | -0.19% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -44,140 | -100.0% | -0.22% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -16,717 | -100.0% | -0.22% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -16,680 | -100.0% | -0.28% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCcall | $0 | – | -40,000 | -100.0% | -0.30% | – |
| SGMO | Exit | SANGAMO THERAPEUTICS INCcall | $0 | – | -40,000 | -100.0% | -0.30% | – |
| KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -19,600 | -100.0% | -0.32% | – |
| PODD | Exit | INSULET CORP | $0 | – | -8,765 | -100.0% | -0.41% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCput | $0 | – | -60,000 | -100.0% | -0.44% | – |
| MODN | Exit | MODEL N INC | $0 | – | -72,283 | -100.0% | -0.50% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -66,600 | -100.0% | -0.85% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -9,400 | -100.0% | -0.88% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -22,524 | -100.0% | -0.99% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -26,800 | -100.0% | -1.16% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -90,000 | -100.0% | -11.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.